Eli Lilly and Company

États‑Unis d’Amérique


 
Quantité totale PI 3 749
Quantité totale incluant filiales 3 931 (+ 182 pour les filiales)
Rang # Quantité totale PI 303
Note d'activité PI 4/5.0    2 555
Rang # Activité PI 254
Activité incl filiales 3,8/5.0    2 570
Symbole boursier
ISIN US5324571083
Capitalisation 722,700M  (USD)
Industrie Drug Manufacturers - Major
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

798 544
370 261
1 012 3
761
 
Dernier brevet 2025 - Kras inhibitors
Premier brevet 1916 - Cephaeline propyl ether and salt
Dernière marque 2025 - IMPACT-D
Première marque 1915 - PULVULES

Filiales

22 subsidiaries with IP (114 patents, 68 trademarks)

16 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Electronic psychological assessment tool consisting primarily of computer software and downloadab...
P/S Medical information services in the field of inflammatory bowel disease and autoimmune diseases a...
P/S Medical and scientific research in the field of Alzheimer’s Disease
P/S Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, A...
P/S Promoting public awareness of obstructive sleep apnea Medical information services in the field o...
P/S Pharmaceutical preparations.
P/S Promoting public awareness of diabetes Medical information services in the field of diabetes
P/S Downloadable software in the nature of a mobile application for providing healthcare-related info...
P/S Platform as a service featuring a clinical site portal for accessing clinical trial applications....
P/S Medical information services in the fields of diabetes, weight loss, sleep apnea, cardiovascular ...
P/S Software for use in providing educational content and training in the field of gastroenterology; ...
P/S Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention an...
P/S Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of obstructive...
P/S Product development; Pharmaceutical products development; Biological development services; Resear...
P/S Medical and scientific research in the field of solid tumors
P/S Venture capital financing; venture capital services, namely, providing financing to seed and earl...
P/S Scientific laboratory services, namely, providing shared wet laboratory facilities and shared lab...
P/S Pharmacy services; online retail pharmacy services; mail order pharmacy services; online retail s...
2024 P/S Patient services programs and related programs and activities relating to Alzheimer patients and ...
P/S Medical information services in the field of atopic dermatitis.
P/S Medical information services
P/S Medical information services in the field of atopic dermatitis
Invention Techniques for processing wirelessly broadcast packets from a medical device with dose-related da...
P/S Medical and scientific research in the field of cardiovascular diseases and disorders
Invention Gip/glp1 co-agonist compounds. The present invention relates to compounds having activity at bot...
Invention Methods of treating ulcerative colitis. The present invention generally relates to the treatment...
P/S Educational services, namely, programs for healthcare personnel about clinical cases and communic...
P/S Medical information services, namely providing information related to Alzheimer's disease
P/S Custom manufacturing of pharmaceuticals and clinical trial materials Pharmaceutical products deve...
Invention Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-n-[6-(1-methyl-pipe...
Invention Kras inhibitors. 1244 are as described herein, pharmaceutically acceptable salts thereof, and met...
Invention Kras inhibitors. The present invention provides compounds of the formula: The present inventio...
Invention Fluidized bed granulation and coating systems and methods. A fluidized bed granulation (FBG) sys...
P/S Pharmaceutical preparations for the treatment of obesity
Invention Incretin analogs and uses thereof. Incretin analogs are provided that have activity at each of t...
Invention Self-healing hydrogel. A self-healing hydrogel which includes a network of poly(3,4- ethylenediox...
Invention Downtime prediction for management of machines in manufacturing network. A method of managing a m...
Invention Neuregulin-4 compounds and methods of use. The present invention relates to neuregulin (NRG) 4 c...
P/S Medical information services, namely, providing information related to diabetes
P/S A tool used for assessing diabetes treatment, namely, printed questionnaires
Invention Pde1 inhibitors. The present invention provides a compound of Formula (I), wherein R1, R2, R3, R4...
Invention Long-acting amylin receptor agonists and uses thereof. The present disclosure relates to the fie...
Invention Methods and systems for managing diabetes. This disclosure relates generally to systems, methods ...
Invention Therapeutic agent delivery device with controls. A therapeutic agent delivery device includes a r...
Invention At2r antagonists and uses thereof. This invention provides certain piperidine compounds as AT2R ...
Invention Process to make glp1 ra and intermediates therefor. The present invention relates to the synthes...
Invention Strain gauge sensor. The present disclosure is directed at a strain gauge sensor, and in particul...
Invention Speed of movement system and method. A system is provided for providing real-time feedback to an ...
Invention (s)-3-((6-fluoropyridin-3-yl)methyl)-1-(5-(pyridin-4-yl)-4h-1,2,4-triazol-3-yl)piperidin-2-one be...
Invention Amyloid precursor protein (app) rnai agents. Provided herein are APP RNAi agents and composition...
Invention Pd-1 agonist antibodies and methods of treating autoimmune diseases with a pd-1 agonist antibody....
Invention Amyloid precursor protein (app) rnai agents. Provided herein are APP RNAi agents and compositions...
Invention Engineered transferrin receptor binding peptides as well as methods of making and using the same....
Invention Process for preparing a gip/glp1 dual agonist. The present invention provides novel intermediate...
Invention Needle system for drug delivery. A needle injection and retraction system mounted within a housin...
Invention Anomaly detection in manufacturing network. A method for detecting anomalies using alarm data fro...
Invention Solid forms of a kv1.3 potassium shaker channel blockers and method of using the same. Solid form...
Invention Piperidine, morpholine and tetrahydro-pyridazine compounds with lp(a) lowering activity. The pres...
Invention Piperidine compounds with lp(a) lowering activity. The present disclosure provides compounds of t...
Invention Root cause analysis for machines in manufacturing network. A method for managing a manufacturing ...
Invention Pyrrolidine compounds lp(a) lowering activity. The present disclosure provides compounds of the f...
Invention Pyrrolidine compounds with lp(a) lowering activity. The present disclosure provides compounds of ...
Invention Fusion proteins. The present invention relates to fusion proteins comprising an insulin receptor...
Invention Compounds and methods targeting epiregulin. The present invention relates to epiregulin antibodi...
Invention Methods and systems for predicting changes in physiological parameters of a patient. The present ...
2023 Invention Regional tau imaging for diagnosing and treating alzheimer's disease. Disclosed are methods for ...
2022 Invention Dosing regimens for selective treg stimulator rur20kd-il-2 and related compositions. The instant...
Invention Systems and methods for identifying subjects for clinical trials. A computing device is provided...
Invention Preserved formulations. Described herein are preserved formulations of insulin-Fc fusions. The f...
Invention Display screen with animated graphical user interface
Invention Display screen with an icon
Invention Anti-il-1-beta antibodies. The present invention provides engineered human interleukin-1 beta an...
Invention Therapeutic agent delivery device with user input. A therapeutic agent delivery device includes ...
Invention Treatment of hand eczema with baricitinib. Methods of treating Hand Eczema with baricitinib, inc...
Invention Box